Youmanitarian 12 Jun 2021

التالي

تشغيل تلقائي

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman

uchetex · 12 المشاهدات

Advances in recurrent endometrial cancer: adavosertib, a WEE1 inhibitor

0

0

14 المشاهدات

TAKE ACTION

Donations would go to support charities for كيف تصمم

في كيف تصمم

Ursula Matulonis, MD, Dana-Farber Cancer Institute, Boston, MA evaluates advances in recurrent endometrial cancer treatment and highlights the development of adavosertib, a WEE1 inhibitor that shows over a 30% response rate and represents an additional therapy for patients with recurrent endometrial cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

أظهر المزيد

More ways to take action

Explore ways that you can help bring a solution to this issue.

Create Youms with
hashtags كيف تصمم

Create a challenge to
bring awareness to this issue for people to complete

Create a fundraiser to
support a charity that tackle this issue

Volunteer at charitable organization
that support this cause

Create a movement page dedicated to this cause to bring awareness.

Start a uCharity for this cause and invite people to join it to support this cause

التالي

تشغيل تلقائي

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman

uchetex · 12 المشاهدات

الصفحة الرئيسية

الاقسام